SCHEMBL6719602

SCHEMBL6719602

Cc1c(C)n(COCc2ccccc2)c(=O)[nH]c1=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.75
TK1 P04183 1/20 0.48
HPGD P15428 4/20 0.46
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 5/20 0.40
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
USP2 O75604 1/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 3/20 0.39
KDM4E B2RXH2 2/20 0.39
DAO P14920 2/20 0.39
PSMD14 O00487 1/20 0.39
HTT P42858 1/20 0.39
UPP1 Q16831 1/20 0.39
XBP1 P17861 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7015162 0.81 ALDH1A1 (0.58) ALDH1A1TK1HPGDCYP2C9CYP2C19
SCHEMBL7834509 0.80 HPGD (0.55) ALDH1A1HPGDKMT2ATSHRSMN1; SMN2
SCHEMBL6722443 0.77 HPGD (0.68) ALDH1A1TK1HPGDMAPK1UPP1
SCHEMBL7219920 0.76 ALDH1A1 (0.52) ALDH1A1TK1HPGDCYP2C9CYP2C19
SCHEMBL27691591 0.74 ALDH1A1 (0.56) ALDH1A1TK1HPGDCYP2C9CYP2C19
SCHEMBL7541222 0.74 ALDH1A1 (0.56) ALDH1A1TK1HPGDCYP2C9CYP2C19
SCHEMBL27691590 0.73 ALDH1A1 (0.70) ALDH1A1TK1HPGDCYP2C9CYP2C19
SCHEMBL27691593 0.73 ALDH1A1 (0.55) ALDH1A1TK1HPGDCYP2C9CYP2C19
SCHEMBL30601622 0.73 ALDH1A1 (0.55) ALDH1A1TK1HPGDCYP2C9CYP2C19
SCHEMBL2786159 0.72 ALDH1A1 (0.54) ALDH1A1TK1HPGDCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6673804-B1 PREVENTING OR TREATING ARTHRITIS (PARTICULARLY OSTEOARTHRITIS) OR INHIBITING METASTASIS, INVASION OR GROWTH OF CANCER (PARTICULARLY BREAST CANCER) SANKYO COMPANY, LIMITED (JP) 2004-01-06 US disclosed
EP-1069110-A1 SULFONAMIDE DERIVATIVES Sankyo Company Limited (JP) 2001-01-17 EP disclosed